If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Lilly is working to develop the Connected Care technologies for patients with diabetes. As with any such effort, pharmaceutical product, or medical device, there are substantial risks and uncertainties in the process of development and commercialization.
There is no guarantee that these platforms will be approved by the FDA, commercially successful, or that the company will meet its anticipated timelines for the rollout of these platforms. While this is one of our priorities, Lilly does not speculate about approval and launch timelines.
DM = diabetes mellitus
FDA = Food and Drug Administration
Lilly = Eli Lilly and Company
Date of Last Review: November 22, 2019